EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Mutations in the transcriptional regulator MAB_2885 confer tedizolid and linezolid resistance through the MmpS-MmpL efflux pump MAB_2302-MAB_2303 in Mycobacterium abscessus

Huiyun Zhang, Shiyong Wang, Yu Zhang, Wenya Hua, Siran Lin, Xinchang Chen, Tao Xu, Jiazhen Chen iD, Wenhong Zhang

PLOS Pathogens · 2025

DOI: 10.1371/journal.ppat.1013190 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS Pathogens, 2025. Verfasst von Huiyun Zhang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Infectious Diseases, Shanghai Key Laboratory of Infectious Diseases and Biosafety Emergency Response, National Medical Center for Infec…. Hauptthemen laut MEDLINE: Mycobacterium abscessus, Anti-Bacterial Agents, Linezolid, Bacterial Proteins. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Key Research and Development Program of China, Major Project of Guangzhou National Laboratory, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Mycobacterium abscessus ( MAB ) is a clinically significant multidrug-resistant (MDR) pathogen, particularly implicated in pulmonary infections among cystic fibrosis (CF) patients. Tedizolid (TZD), an oxazolidinone-class antibacterial drug, has been recommended as an alternative treatment for MAB -infected patients who are intolerant to or whose isolate is resistant to first-line drugs including linezolid (LZD). To investigate the TZD resistance mechanisms in MAB , we isolated 23 TZD-resistant MAB mutants and performed whole-genome sequencing (WGS) to identify resistance-associated genes. Frequent mutations were identified in MAB_2885 , encoding a putative TetR transcriptional regulator, and MAB_2303 , encoding a putative mycobacterial membrane protein large (MmpL). Drug susceptibility testing confirmed that MAB_2885 mutations contribute to both TZD and LZD resistance in MAB . RNA-seq analysis revealed that restoring wild-type MAB_2885 in mutants downregulated the MAB_2302-MAB_2303 . Electrophoretic mobility shift assay (EMSA) showed the MAB_2885 protein binds to its target sequence upstream of MAB_2302-MAB_2303 , further confirming their regulatory relationship. The W91R mutation in the MAB_2885 protein was found to impair its DNA-binding activity compared to the wild-type. Liquid chromatography-tandem mass spectrometry (LC-MS/MS) analysis confirmed that MAB_2302-MAB_2303 functions as a TZD efflux pump. Additionally, overexpression of MAB_2885 in M. abscessus subsp. bolletii and M. abscessus subsp. massiliense also increased their TZD susceptibility and downregulated their respective MmpS-MmpL orthologs. Overall, our study demonstrates that mutations in MAB_ 2885 contribute to TZD and LZD resistance by disrupting the negative regulation of the downstream MAB_2302-MAB_2303, which functions as a direct efflux pump for TZD. These findings provide new insights into oxazolidinone resistance mechanisms in MAB and identify potential biomarkers for detecting drug resistance.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Mycobacterium abscessusAnti-Bacterial AgentsLinezolidBacterial ProteinsMycobacterium Infections, NontuberculousOxazolidinonesDrug Resistance, BacterialDrug Resistance, Multiple, BacterialMutationHumansMicrobial Sensitivity TestsTetrazoles

Substanzen

Anti-Bacterial AgentsLinezolidBacterial ProteinstedizolidOxazolidinonesTetrazoles

Autor:innen und Institutionen

  • Department of Infectious Diseases, Shanghai Key Laboratory of Infectious Diseases and Biosafety Emergency Response, National Medical Center for Infectious Diseases, Huashan Hospital, Shanghai Medical College, Fudan Univ…
  • Shanghai Sci-Tech Inno Center for Infection & Immunity, Shanghai, China.

ORCID-Profile: Jiazhen Chen

Förderung

  • National Key Research and Development Program of China
  • Major Project of Guangzhou National Laboratory
  • National Natural Science Foundation of China
  • Shanghai Sailing Program
  • National Key Research and Development Program of China Stem Cell and Translational Research

Zitieren

APA

Zhang, H., Wang, S., Zhang, Y., Hua, W., Lin, S., Chen, X., Xu, T., Chen, J., & Zhang, W. (2025). Mutations in the transcriptional regulator MAB_2885 confer tedizolid and linezolid resistance through the MmpS-MmpL efflux pump MAB_2302-MAB_2303 in Mycobacterium abscessus. PLOS Pathogens. https://doi.org/10.1371/journal.ppat.1013190

Vancouver

Zhang H, Wang S, Zhang Y, Hua W, Lin S, Chen X, et al. Mutations in the transcriptional regulator MAB_2885 confer tedizolid and linezolid resistance through the MmpS-MmpL efflux pump MAB_2302-MAB_2303 in Mycobacterium abscessus. PLOS Pathogens. 2025. doi:10.1371/journal.ppat.1013190

BibTeX
@article{Zhang2025,
  author = {Zhang, Huiyun and Wang, Shiyong and Zhang, Yu and Hua, Wenya and Lin, Siran and Chen, Xinchang and Xu, Tao and Chen, Jiazhen and Zhang, Wenhong},
  title = {Mutations in the transcriptional regulator MAB_2885 confer tedizolid and linezolid resistance through the MmpS-MmpL efflux pump MAB_2302-MAB_2303 in Mycobacterium abscessus},
  journal = {PLOS Pathogens},
  year = {2025},
  doi = {10.1371/journal.ppat.1013190}
}
Kostenlos starten →